Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of mouse macrophages to investigate how interferon gene therapy reprograms the leukemia microenvironment

ABSTRACT: RNA-seq of mouse macrophages to investigate how interferon gene therapy reprograms the leukemia microenvironment

PROVIDER: PRJEB27014 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2601400.fastq.gz	Fastqsanger.gz
	ERR2601410.fastq.gz	Fastqsanger.gz
	ERR2601401.fastq.gz	Fastqsanger.gz
	ERR2601402.fastq.gz	Fastqsanger.gz
	ERR2601403.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 11

Similar Datasets

E-MTAB-6482

Project description:RNA-seq of mouse macrophages to investigate how interferon gene therapy reprograms the leukemia microenvironment

2018-09-17 | E-MTAB-6482 | ExpressionAtlas

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens

Project description:Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens

| PRJEB32595 | ENA

RNA-seq of mouse macrophages to investigate how interferon gene therapy reprograms the leukemia microenvironment

Project description:Bulk transcriptome profiling of macrophages isolated from the spleen of control and tumor-bearing mice, treated or not with IFN gene therapy.

2018-07-26 | E-MTAB-6482 | biostudies-arrayexpress

Chemohormonal Therapy Remodels Prostate Cancer Immune Microenvironment and Enhances Checkpoint Inhibitor-based immunotherapy

Project description:Checkpoint blockade immunotherapy is a promising strategy in cancer treatment, depending on a favorable preexisting tumor immune microenvironment. However, prostate cancer is usually considered as an immune “cold” tumor with the poor immunogenic response and low density of tumor-infiltrating immune cells. This research uses samples from prostate cancer patients showing that docetaxel-based chemohormonal therapy reprograms the immune microenvironment and increases tumor-infiltrating T cells. Mechanistically, docetaxel treatment activates the cGAS/STING pathway and induces the type I interferon signaling, which may boost T cell-mediated immune response. In a murine prostate cancer model, chemohormonal therapy sensitizes tumor-bearing mice to PD1-blockade therapy. These findings demonstrate that docetaxel-based chemohormonal therapy activates prostate cancer immunogenicity and acts cooperatively with anti-PD-1 checkpoint blockade, providing a combination immunotherapy strategy that would lead to better therapeutic benefit for prostate cancer.

2022-08-01 | GSE193898 | GEO

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens

Project description:Single-cell transcriptome profiling using a 3' droplet-based platform (Chromium,10x Genomics) of CD11b+ cells isolated from the spleen of control and tumor-bearing mice, treated or not with IFN gene therapy.

2019-05-16 | E-MTAB-6487 | biostudies-arrayexpress

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens.

Project description:Immunotherapy is emerging as a new pillar of cancer treatment with potential to cure. However, many patients still fail to respond to these therapies. Among the underlying factors, an immunosuppressive tumor microenvironment (TME) plays a major role. Here we show that monocyte-mediated gene delivery of IFNα inhibits leukemia in a mouse model. IFN gene therapy counteracts leukemia-induced expansion of immunosuppressive myeloid cells and imposes an immunostimulatory program to the TME, as shown by bulk and single-cell transcriptome analyses. This reprogramming promotes T-cell priming and effector function against multiple surrogate tumor-specific antigens, inhibiting leukemia growth in our experimental model. Durable responses are observed in a fraction of mice and are further increased combining gene therapy with checkpoint blockers. Furthermore, IFN gene therapy strongly enhances anti-tumor activity of adoptively transferred T cells engineered with tumor-specific TCR or CAR, overcoming suppressive signals in the leukemia TME. These findings warrant further investigations on the potential development of our gene therapy strategy towards clinical testing.

| S-EPMC6057972 | biostudies-literature

MYC oncogene reprograms the local tissue microenvironment during prostate carcinogenesis

Project description:MYC oncogene reprograms the local tissue microenvironment during prostate carcinogenesis

| PRJNA952229 | ENA

Targeting METTL3 reprograms tumor microenvironment to improve cancer immunotherapy [RNA-seq]

Project description:Targeting METTL3 reprograms tumor microenvironment to improve cancer immunotherapy [RNA-seq]

| PRJNA874419 | ENA

SMALL EXTRACELLULAR VESICLE REGULATION OF MITOCHONDRIAL DYNAMICS REPROGRAMS A HYPOXIC TUMOR MICROENVIRONMENT

Project description:SMALL EXTRACELLULAR VESICLE REGULATION OF MITOCHONDRIAL DYNAMICS REPROGRAMS A HYPOXIC TUMOR MICROENVIRONMENT

| PRJNA645917 | ENA

MYC oncogene reprograms the local tissue microenvironment during prostate carcinogenesis

Project description:To investigate the casual sequelae of MYC activation in the prostate tumor microenvironment (TME), we modeled MYC activation in the prostate TME using the transgenic Hi-Myc mouse model of prostate cancer.

2023-10-16 | GSE228945 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data